These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2927501)

  • 21. New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL).
    Cambier JC
    Immunol Today; 1995 Feb; 16(2):110. PubMed ID: 7888063
    [No Abstract]   [Full Text] [Related]  

  • 22. Initiation and processing of signals from the B cell antigen receptor.
    Reth M; Wienands J
    Annu Rev Immunol; 1997; 15():453-79. PubMed ID: 9143696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation.
    Daëron M; Latour S; Malbec O; Espinosa E; Pina P; Pasmans S; Fridman WH
    Immunity; 1995 Nov; 3(5):635-46. PubMed ID: 7584153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEM.
    Saotome K; Dudgeon D; Colotti K; Moore MJ; Jones J; Zhou Y; Rafique A; Yancopoulos GD; Murphy AJ; Lin JC; Olson WC; Franklin MC
    Nat Commun; 2023 Apr; 14(1):2401. PubMed ID: 37100770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards a unifying model for B-cell receptor triggering.
    Degn SE; Tolar P
    Nat Rev Immunol; 2024 Sep; ():. PubMed ID: 39256626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity.
    Xiao L; Zhang L; Guo C; Xin Q; Gu X; Jiang C; Wu J
    Cancer Commun (Lond); 2024 Jul; 44(7):791-832. PubMed ID: 38923737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-independent B-cell effect of agents associated with swine grower-finisher diarrhea.
    Barbosa JA; Yang CT; Finatto AN; Cantarelli VS; de Oliveira Costa M
    Vet Res Commun; 2024 Apr; 48(2):991-1001. PubMed ID: 38044397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.
    Gaud G; Achar S; Bourassa FXP; Davies J; Hatzihristidis T; Choi S; Kondo T; Gossa S; Lee J; Juneau P; Taylor N; Hinrichs CS; McGavern DB; François P; Altan-Bonnet G; Love PE
    Nat Immunol; 2023 Dec; 24(12):2121-2134. PubMed ID: 37945821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FCRL1 immunoregulation in B cell development and malignancy.
    Mamidi MK; Huang J; Honjo K; Li R; Tabengwa EM; Neeli I; Randall NL; Ponnuchetty MV; Radic M; Leu CM; Davis RS
    Front Immunol; 2023; 14():1251127. PubMed ID: 37822931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Story of Kinases and Adaptors: The Role of Lck, ZAP-70 and LAT in Switch Panel Governing T-Cell Development and Activation.
    Fernández-Aguilar LM; Vico-Barranco I; Arbulo-Echevarria MM; Aguado E
    Biology (Basel); 2023 Aug; 12(9):. PubMed ID: 37759563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovering immunoreceptor coupling and organization motifs.
    Reth M
    Front Immunol; 2023; 14():1253412. PubMed ID: 37731510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulating T Cell Responses by Targeting CD3.
    Menon AP; Moreno B; Meraviglia-Crivelli D; Nonatelli F; Villanueva H; Barainka M; Zheleva A; van Santen HM; Pastor F
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR".
    Teppert K; Wang X; Anders K; Evaristo C; Lock D; Künkele A
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell and B cell antigen receptors share a conserved core transmembrane structure.
    Ramesh S; Park S; Im W; Call MJ; Call ME
    Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2208058119. PubMed ID: 36409917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural principles of B cell antigen receptor assembly.
    Dong Y; Pi X; Bartels-Burgahn F; Saltukoglu D; Liang Z; Yang J; Alt FW; Reth M; Wu H
    Nature; 2022 Dec; 612(7938):156-161. PubMed ID: 36228656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial requirements for ITAM signaling in an intracellular natural killer cell model membrane.
    Chong G; MacKerell AD
    Biochim Biophys Acta Gen Subj; 2022 Nov; 1866(11):130221. PubMed ID: 35933027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors.
    Yu T; Yu SK; Xiang Y; Lu KH; Sun M
    Front Immunol; 2022; 13():936496. PubMed ID: 35903099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fumarate suppresses B-cell activation and function through direct inactivation of LYN.
    Cheng J; Liu Y; Yan J; Zhao L; Zhou Y; Shen X; Chen Y; Chen Y; Meng X; Zhang X; Jiang P
    Nat Chem Biol; 2022 Sep; 18(9):954-962. PubMed ID: 35710616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies.
    Ramos-Mejia V; Arellano-Galindo J; Mejía-Arangure JM; Cruz-Munoz ME
    Front Immunol; 2022; 13():803995. PubMed ID: 35493522
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.